HIV & AIDS

Novel vaccine approach to human cytomegalovirus found effective

An experimental vaccine against human cytomegalovirus (CMV) infection, which endangers the developing fetus, organ transplant recipients, patients with HIV and others who have a weakened immune system, proved safe and more ...

Alzheimer's disease & dementia

New drug reverses loss of brain connections in Alzheimer's disease

The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines ...

Diseases, Conditions, Syndromes

Academies urge new measures against drug-resistant bacteria

Fewer and fewer antibiotics are available for an increasing number of infections caused by antibiotic-resistant bacteria. As a result, it is becoming increasingly difficult to treat infected patients successfully. The Academy ...

Medical research

Scientists create personalized bone substitutes from skin cells

A team of New York Stem Cell Foundation (NYSCF) Research Institute scientists report today the generation of patient-specific bone substitutes from skin cells for repair of large bone defects. The study, led by Darja Marolt, ...

page 5 from 9